DYRK3
Basic information
Region (hg38): 1:206635536-206684419
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DYRK3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 23 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 23 | 1 | 0 |
Variants in DYRK3
This is a list of pathogenic ClinVar variants found in the DYRK3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-206637702-C-G | not specified | Uncertain significance (Mar 28, 2024) | ||
1-206637703-C-T | not specified | Uncertain significance (Nov 27, 2024) | ||
1-206647401-A-G | not specified | Uncertain significance (Nov 07, 2024) | ||
1-206647445-A-T | not specified | Uncertain significance (Oct 02, 2023) | ||
1-206647466-C-G | not specified | Uncertain significance (Sep 26, 2024) | ||
1-206647556-A-C | not specified | Uncertain significance (Apr 08, 2022) | ||
1-206647565-T-C | not specified | Uncertain significance (Oct 20, 2024) | ||
1-206647577-G-A | not specified | Uncertain significance (Jun 12, 2023) | ||
1-206647584-C-T | not specified | Uncertain significance (Mar 28, 2024) | ||
1-206647755-A-G | not specified | Uncertain significance (Oct 18, 2021) | ||
1-206647772-G-A | not specified | Uncertain significance (Apr 23, 2024) | ||
1-206647778-G-T | not specified | Uncertain significance (Jan 26, 2022) | ||
1-206647915-G-T | not specified | Uncertain significance (Jan 19, 2024) | ||
1-206647920-G-A | not specified | Uncertain significance (Nov 13, 2024) | ||
1-206647940-C-T | not specified | Uncertain significance (Nov 29, 2023) | ||
1-206647961-C-T | not specified | Uncertain significance (Nov 13, 2024) | ||
1-206647962-G-A | not specified | Uncertain significance (Jul 05, 2023) | ||
1-206647988-G-A | not specified | Uncertain significance (Jul 12, 2022) | ||
1-206647991-A-G | not specified | Uncertain significance (May 31, 2023) | ||
1-206648018-A-T | not specified | Uncertain significance (Apr 18, 2024) | ||
1-206648025-A-G | not specified | Uncertain significance (Sep 22, 2023) | ||
1-206648035-A-T | Likely benign (Mar 01, 2024) | |||
1-206648103-A-G | not specified | Uncertain significance (May 17, 2023) | ||
1-206648135-C-T | not specified | Uncertain significance (Oct 03, 2022) | ||
1-206648201-G-C | not specified | Uncertain significance (Dec 03, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DYRK3 | protein_coding | protein_coding | ENST00000367109 | 3 | 48884 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000358 | 0.820 | 125645 | 1 | 102 | 125748 | 0.000410 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.186 | 302 | 311 | 0.970 | 0.0000173 | 3858 |
Missense in Polyphen | 167 | 181.79 | 0.91863 | 2274 | ||
Synonymous | -1.09 | 126 | 111 | 1.13 | 0.00000548 | 1174 |
Loss of Function | 1.36 | 11 | 17.1 | 0.645 | 9.43e-7 | 241 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00157 | 0.00157 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000317 | 0.000316 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.000229 | 0.000229 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Dual-specificity protein kinase that promotes disassembly of several types of membraneless organelles during mitosis, such as stress granules, nuclear speckles and pericentriolar material (PubMed:29973724). Dual-specificity tyrosine-regulated kinases (DYRKs) autophosphorylate a critical tyrosine residue in their activation loop and phosphorylate their substrate on serine and threonine residues (PubMed:9748265, PubMed:29634919). Acts as a central dissolvase of membraneless organelles during the G2-to-M transition, after the nuclear- envelope breakdown: acts by mediating phosphorylation of multiple serine and threonine residues in unstructured domains of proteins, such as SRRM1 and PCM1 (PubMed:29973724). Does not mediate disassembly of all membraneless organelles: disassembly of P-body and nucleolus is not regulated by DYRK3 (PubMed:29973724). Dissolution of membraneless organelles at the onset of mitosis is also required to release mitotic regulators, such as ZNF207, from liquid-unmixed organelles where they are sequestered and keep them dissolved during mitosis (PubMed:29973724). Regulates mTORC1 by mediating the dissolution of stress granules: during stressful conditions, DYRK3 partitions from the cytosol to the stress granule, together with mTORC1 components, which prevents mTORC1 signaling (PubMed:23415227). When stress signals are gone, the kinase activity of DYRK3 is required for the dissolution of stress granule and mTORC1 relocation to the cytosol: acts by mediating the phosphorylation of the mTORC1 inhibitor AKT1S1, allowing full reactivation of mTORC1 signaling (PubMed:23415227). Also acts as a negative regulator of EPO-dependent erythropoiesis: may place an upper limit on red cell production during stress erythropoiesis (PubMed:10779429). Inhibits cell death due to cytokine withdrawal in hematopoietic progenitor cells (PubMed:10779429). Promotes cell survival upon genotoxic stress through phosphorylation of SIRT1: this in turn inhibits p53/TP53 activity and apoptosis (PubMed:20167603). {ECO:0000269|PubMed:10779429, ECO:0000269|PubMed:20167603, ECO:0000269|PubMed:23415227, ECO:0000269|PubMed:29634919, ECO:0000269|PubMed:29973724, ECO:0000269|PubMed:9748265}.;
- Pathway
- EGFR1
(Consensus)
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- loftool
- 0.916
- rvis_EVS
- 0.17
- rvis_percentile_EVS
- 65.96
Haploinsufficiency Scores
- pHI
- 0.187
- hipred
- N
- hipred_score
- 0.408
- ghis
- 0.499
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.745
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dyrk3
- Phenotype
- hematopoietic system phenotype;
Gene ontology
- Biological process
- protein phosphorylation;cell cycle;peptidyl-tyrosine phosphorylation;erythrocyte differentiation;nuclear speck organization;stress granule disassembly;negative regulation of apoptotic process;negative regulation of DNA damage response, signal transduction by p53 class mediator;cell division;regulation of cellular response to stress;positive regulation of cell cycle G2/M phase transition;organelle disassembly;regulation of TORC1 signaling
- Cellular component
- pericentriolar material;nucleus;nucleoplasm;cytoplasm;cytosol;cytoplasmic stress granule;nuclear speck;intracellular membrane-bounded organelle
- Molecular function
- magnesium ion binding;protein kinase activity;protein serine/threonine kinase activity;protein serine/threonine/tyrosine kinase activity;protein tyrosine kinase activity;ATP binding